Jagjit Singh
Overview
Explore the profile of Jagjit Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
924
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalsi S, Singh J, Saini K, Sharma N
Proc Inst Mech Eng H
. 2025 Jan;
239(1):72-82.
PMID: 39785362
Bone is a highly heterogeneous and anisotropic material with a hierarchical structure. The effect of diaphysis locations and directions of loading on elastic-plastic compressive properties of bovine femoral cortical bone...
2.
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Davar D, Morrison R, Dzutsev A, Karunamurthy A, Chauvin J, Amatore F, et al.
Cancer Cell
. 2024 Nov;
42(11):1898-1918.e12.
PMID: 39486411
Intratumoral TLR9 agonists and anti-PD-1 produce clinical responses and broad immune activation. We conducted a single-arm study of neoadjuvant TLR9 agonist vidutolimod combined with anti-PD-1 nivolumab in high-risk resectable melanoma....
3.
Singh A, Singh J, Parween G, Khator R, Monga V
Crit Rev Food Sci Nutr
. 2024 Aug;
:1-37.
PMID: 39154213
A multitude of plant-derived bioactive compounds have shown significant promise in preventing chronic illnesses, with flavonoids constituting a substantial class of naturally occurring polyphenolic compounds. Apigenin, a flavone identified as...
4.
Sharm J, Gautam C, Singh H, Singh J
Indian J Med Res
. 2023 Oct;
158(2):207-210.
PMID: 37787262
No abstract available.
5.
Singh J, Habean M, Panicker N
Trends Neurosci
. 2023 Aug;
46(10):814-831.
PMID: 37633753
Neurodegenerative disorders are characterized by the progressive dysfunction and death of selectively vulnerable neuronal populations, often associated with the accumulation of aggregated host proteins. Sustained brain inflammation and hyperactivation of...
6.
Singh H, Singh J, Bhangu R, Singla M, Singh J, Javid F
Expert Rev Clin Pharmacol
. 2022 Dec;
16(1):49-59.
PMID: 36567479
Introduction: Based on pharmacological properties and results from clinical studies, teneligliptin has a great potential to be used as an alternate-day therapy and also the daily dose can be reduced...
7.
Thapliyal S, Singh J, Mamgain M, Kumar A, Bisht M, Singh A, et al.
Cureus
. 2022 Dec;
14(10):e30892.
PMID: 36465733
Background Lamotrigine (LTG) and subconvulsive doses of pentylenetetrazol (PTZ) as a model mimic drug-resistant epilepsy (DRE), which is a serious unmet medical condition. Previous evidence suggests an imperative role of...
8.
Singh J, Thapliyal S, Kumar A, Paul P, Kumar N, Bisht M, et al.
Cureus
. 2022 Oct;
14(9):e28818.
PMID: 36225395
Background Paclitaxel (PTX)-induced peripheral neuropathy (PIPN) is nonresponsive to the currently available analgesics. Previous studies have shown the role of oxidative stress and central sensitization in the development of peripheral...
9.
Kumar A, Mahajan A, Kumari P, Singh J, Raik S, Saha L, et al.
Cell Biochem Funct
. 2022 Jul;
40(5):535-545.
PMID: 35790015
Advancing age is associated with several diseases and disorders due to multiorgan atrophy. The increasing proportion of elderly humans demands the identification of means to counteract aging and age-associated disorders....
10.
Sharma J, Gautam C, Singh H, Singh J
Indian J Med Res
. 2022 Jun;
154(6):797-805.
PMID: 35662084
Plasmodium vivax (P. vivax) malaria is a major problem in various countries such as America, Southeast Asia, Africa and the Eastern Mediterranean. The major barrier in controlling P. vivax malaria...